A Phase II Trial of Isolated Limb Infusion With Melphalan and Dactinomycin for Regional Melanoma and Soft Tissue Sarcoma of the Extremity

By Brady Mary   Brown Karen   Patel Ami   Fisher Charles   Marx Will  

Annals of Surgical Oncology, Vol. 13, Iss. 8, 2006-08 ,pp. : 1123-1129

Springer Publishing Company

Access to resources Recommend Favorite

Isolated Limb Perfusion With Melphalan and Tumor Necrosis Factor α for Advanced Melanoma and Soft-Tissue Sarcoma

By Hayes Andrew   Neuhaus Susan   Clark Matthew   Thomas J.  

Annals of Surgical Oncology, Vol. 14, Iss. 1, 2007-01 ,pp. : 230-238

Springer Publishing Company

Access to resources Recommend Favorite

Long-Term Results of Melphalan-Based Isolated Limb Perfusion With or Without Low-Dose TNF for In-Transit Melanoma Metastases

By Rossi Carlo  

Annals of Surgical Oncology, Vol. 17, Iss. 11, 2010-11 ,pp. : 3000-3007

Springer Publishing Company

Access to resources Recommend Favorite

A Single Centre's 10 Year Experience With Isolated Limb Perfusion in the Treatment of Recurrent Malignant Melanoma of the Limb

By Lingam M.K.   Byrne D.S.   Aitchison T.   MacKie R.M.   McKay A.J.  

European Journal of Cancer, Vol. 32, Iss. 10, 1996-09 ,pp. : 1668-1673

Elsevier

Access to resources Recommend Favorite

Long-term outcome of hyperthermic isolated limb perfusion (HILP) in the treatment of locoregionally metastasised malignant melanoma of the extremities

By Boesch Cedric E.   Meyer Thomas   Waschke Lena   Merkel Susanne   Goehl Jonas   Hohenberger Werner   Knorr Christian  

International Journal of Hyperthermia, Vol. 26, Iss. 1, 2010-06 ,pp. : 16-20

Informa Healthcare

Access to resources Recommend Favorite